We have identified a factor present in nuclear extracts of undifferentiated F9 murine embryonal carcinoma cells that specifically interacts with the polyomavirus enhancer region. Nuclease "footprint" analysis was used to define the binding site that corresponds precisely to the boundaries of polyoma enhancer element C defined by Veldman et al. [Veldman, G. M., Lupton, S. & Kamen, R. (1985) Mol. CeU. Biol. 5,[649][650][651][652][653][654][655][656][657][658] that is required as an enhancer for efficient viral DNA replication and early and late region transcription. We are interested in host factors that bind to the murine polyomavirus enhancer region. The polyoma enhancer is particularly interesting because this region regulates viral expression in a developmentally specific fashion (see ref. 6 for a review) and also is required for efficient viral DNA replication (7). deVilliers and Schaffner (8) originally identified an enhancer located in the noncoding sequences of the polyoma genome [nucleotides (nt) 5021-5262, Fig. 1 ]. This region has an altered chromatin structure (17) and contains control elements for the early and late transcription units and the origin of DNA replication (refs. 7, 8, and 17-22; Fig. 1 (24), we have identified a factor present in undifferentiated F9 cell nuclear extracts that binds both wt and hrN2 enhancer regions. This factor also was found in nuclear extracts from differentiated F9 cells, murine L cells, and human HeLa cells. Nuclease protection experiments showed that this factor binds precisely within the boundaries of enhancer element C (Fig. 1) . (25) were washed in lysis buffer minus Nonidet P-40, and nuclear proteins were extracted using 0.3 M NaCl as described (26) with the exception that the 0.1 M NaCl wash was omitted. Extracts were dialyzed for 4 hr at 40C against 20 mM Tris'HCl, pH 7.4/50 mM NaCl/25% (vol/vol) glycerol/0.1 mM EGTA/0.1 mM EDTA/0.5 mM dithiothreitol/phenylmethylsulfonyl fluoride at 85 pg/ml and stored in liquid nitrogen. Protein concentrations were determined by the method of Bradford (27) 
Eukaryotic enhancer sequences regulate a variety ofviral and cellular genes (reviewed in refs. 1 and 2). By definition, enhancers activate transcription of a gene linked in cis in a relatively orientation-and location-independent fashion. Enhancer elements have been shown to display tissue and species specificity and to activate transcription over large distances (1, 2) . Although the mechanism(s) of enhancer function is unclear, these sequences have been shown to bind trans-acting cellular factors (3) (4) (5) .
We are interested in host factors that bind to the murine polyomavirus enhancer region. The polyoma enhancer is particularly interesting because this region regulates viral expression in a developmentally specific fashion (see ref. 6 for a review) and also is required for efficient viral DNA replication (7) . deVilliers and Schaffner (8) originally identified an enhancer located in the noncoding sequences of the polyoma genome [nucleotides (nt) 5021-5262, Fig. 1 ]. This region has an altered chromatin structure (17) and contains control elements for the early and late transcription units and the origin of DNA replication (refs. 7, 8, and 17-22; Fig. 1 ). Genetic analyses have demonstrated that the organization of the polyoma enhancer is complex and functionally redundant (although not sequence redundant). At least five separate domains appear to contribute to the enhancer function of this region (regions A-E, Fig. 1 ; refs. 7 and 14-16; also see ref.
6 for a review). The multiple nature and functional redundance of the polyoma enhancer sequences may reflect a capability to utilize a variety of cellular factors to obtain optimal enhancer activity.
Polyomavirus lytic growth is restricted in a number of undifferentiated mouse cell lines that include the embryonal carcinoma lines F9 and PCC-4 as well as trophoblast and neuroblastoma cell lines. Polyoma host range mutants adapted for growth in these undifferentiated cells contain complex point and deletion mutations, duplications, and rearrangements in the enhancer region (reviewed in ref. 6 ). The genetic alterations in these mutants confirm the importance of the enhancer regions discussed above (regions A-E, Fig. 1 ). Our studies have focused on the enhancer region ofwild-type (wt) polyoma and one prototypic F9 host range mutant (hrN2; ref. 23) . Utilizing a sensitive filter binding assay to detect DNA-protein complexes (24) , we have identified a factor present in undifferentiated F9 cell nuclear extracts that binds both wt and hrN2 enhancer regions. This factor also was found in nuclear extracts from differentiated F9 cells, murine L cells, and human HeLa cells. Nuclease protection experiments showed that this factor binds precisely within the boundaries of enhancer element C (Fig. 1 ).
METHODS
Preparation of Nuclear Extract. Isolated nuclei (25) were washed in lysis buffer minus Nonidet P-40, and nuclear proteins were extracted using 0.3 M NaCl as described (26) with the exception that the 0.1 M NaCl wash was omitted. Extracts were dialyzed for 4 hr at 40C against 20 mM Tris'HCl, pH 7.4/50 mM NaCl/25% (vol/vol) glycerol/0.1 mM EGTA/0.1 mM EDTA/0.5 mM dithiothreitol/phenylmethylsulfonyl fluoride at 85 pg/ml and stored in liquid nitrogen. Protein concentrations were determined by the method of Bradford (27) . Plasmids (12); BPV, bovine papilloma virus enhancer homology (13) . EF-C is the region of nuclease protection described in this report, and the arrows indicate repeated sequences in this element. C, single copy of the repeat in the EF-C binding domain; TATA, TATA box promoter homology. A, B, C, and D indicate elements of the polyoma enhancer defined by Veldman et al. (14) . Region E corresponds to an additional enhancer region generated in polyoma F9 host range mutants (15, 16) .
Sma I (converted to Xho I via a linker) sites. The clone displayed in Fig. 5 (pUC-EFC) was selected for these studies. 32P-labeled DNA was added (2500-6000 cpm corresponding to 33-80 pg of DNA), and the reaction was continued for 30 min at room temperature. Reactions were slowly filtered through nitrocellulose using a Schleicher & Schuell manifold. The filter was washed three times with 0.25 ml of ice cold 25 mM Hepes-KOH, pH 7.4/5 mM MgCl; and either the filter was exposed to x-ray film, or the radioactivity in the dots was measured directly by liquid scintillation counting.
Binding reactions for DNase I footprint analysis were scaled up 5-fold. Following the binding reaction, 12 ,Al of DNase I (Worthington; concentrations are in the figure legends) in 25 mM Hepes-KOH, pH 7.5/100 mM MgCl2 and 50 mM CaCl2 were added, and the reaction mixtures were incubated for 5 min at room temperature. DNase I concentrations that yielded single hit kinetics were determined empirically. Reactions were terminated by the addition of 250 ,ul of 100 mM Tris HCl, pH 8.0/20 mM EDTA/0.5% NaDod-S04/0.15 M NaCl/tRNA at 50 ,g/ml, followed by extraction with phenol/chloroform (1:1, vol/vol), chloroform, and subsequent ethanol precipitation. Samples were electrophoresed in 8% polyacrylamide/urea denaturing gels. Marker sequencing ladders were generated using homologous fragments by the procedure of Maxam and Gilbert (28) . Cell Culture. F9 thymidine kinase deficient (F9 tk-) embryonal carcinoma cells (29) , kindly provided by Barbara Knowles (Wistar Institute, Philadelphia) were plated on gelatin-coated dishes in Delbecco's modified Eagle's medium (DMEM) containing 10% (vol/vol) fetal bovine serum. F9 cells were stimulated to differentiate with 50 nM retinoic acid and 0.1 mM dibutyrl cyclic AMP as described (30) and were harvested 3-4 days later. Differentiation was monitored visually and by assaying plasminogen activator activity (30) . HeLa cells were cultured in suspension in the suspension formulation of Eagle's modified essential medium (SMEM) containing 7% (vol/vol) calf serum, and L cells were grown on dishes in DMEM containing 10% (vol/vol) calf serum.
RESULTS
A nitrocellulose filter binding assay (24) was employed to detect factors that specifically bind to polyoma Pvu II fragment 4 (nt 5128-5262, Fig. 1 ) from the wt and the F9 hrN2 mutant. The Pvu II fragment 4 contains enhancer elements B, C, and E (Fig. 1) . Region E is altered by point mutation (adenosine to guanosine transition at nt 5230) and subsequent duplication (nt 5214-5246) in the hrN2 mutant (18) . Extracts contained proteins eluted from nuclei using 0.3 M NaCl.
The results of a filter binding assay using a nuclear extract from undifferentiated F9 cells is shown in Fig. 2 . Binding of a pBR322 control fragment occurred in the absence of competitor DNA but was eliminated with increasing concentrations of competitor in the reaction. Similar results were obtained with other control fragments (data not shown). In contrast, binding of the wt or hrN2 Pvu II fragments 4 was observed even at high concentrations of competitor DNA. Similar titrations using nuclear extracts from differentiated F9 cells and human HeLa cells (Fig. 2) followed by DNase I digestion to give single nuclease cuts per molecule. As shown in Fig. 3 , identical regions of protection were detected with the wt polyoma and hrN2 fragments using nuclear extracts from undifferentiated F9 cells. The footprint is located between nt 5155 and 5174. An identical region of protection was obtained using wt and hrN2 fragments labeled at the opposite end (nt 5262) with 32p (data not shown). Using these conditions, no protection was detected in either the wt or hrN2 fragments corresponding to enhancer elements B or E. Footprint analyses also were performed using nuclear extracts from differentiated F9 cells and human HeLa cells (Fig. 4) . The same region of protection (nt 5155-5174) again was observed with Pvu II fragment 4 from the hrN2 (Fig. 4) and wt (data not shown).
The polyoma nucleotide sequence around the region of the footprint is shown in Fig. 5 . A 6-bp inverted repeat is located precisely within the boundaries of the region of nuclease protection. The repeated sequences (5' AGTTGC 3') are separated by 3 bp. A single copy of this sequence is located on the early side of the polyoma origin of DNA replication (nt 63-68, Fig. 1 ). We tested whether this sequence was capable ofbinding the factor using the filter binding assay. A fragment spanning this region (nt 5262-162, Fig. 1 2 3 4 5 6 7 8 2 3 4 5 6 7 8 To test whether sequences outside the footprint are required for binding, a plasmid (pUC-EFC) was constructed that contains polyoma nt 5150-5178 inserted in pUC9 (Fig. 5) . The polyoma sequences in this plasmid contain the region of nuclease protection (nt 5155-5174) plus only 5 bp upstream and 4 bp downstream from this region. This fragment was excised from the vector using restriction sites that flank the polyoma sequences (Fig. 5 (Fig. 6 ).
DISCUSSION
We have identified a nuclear factor that specifically binds to the polyomavirus enhancer region. This factor is present in nuclear extracts prepared from undifferentiated and differentiated F9 murine embryonal carcinoma cells as well as differentiated murine L and human HeLa cells. The binding activity in each of these extracts is similar, suggesting that expression of this factor is not regulated by the state of cell differentiation. The fact that this factor is found in mouse and human cells is not surprising since the polyoma enhancer region functions in both cell types (31) The region of nuclease protection conferred by factor binding (nt 5155-5174) corresponds precisely to enhancer element C (nt 5148-5179, Fig. 1 ) defined by the genetic analyses of Veldman et al. (14) . This region is required for efficient polyoma DNA replication in vivo (7, 14) . Enhancer element C in conjunction with element A (the ElA enhancer homology, Fig. 1 ) represent the predominant enhancer elements in the polyoma enhancer region that are required for viral DNA replication (14) . Specific deletion of these two elements (deletion of nt 5101-5165) abolishes replication enhancer function of the entire enhancer region (nt 5021-5262; ref. 14) . Enhancer element C also regulates transcription of both the early and late regions of the polyoma genome (7, 22) . We define the factor that interacts with this region as EF-C, enhancer binding factor to polyoma element C.
The boundaries of the EF-C binding domain also correlate with the ( regulatory region (nt 5157-5181) defined by Maione et al. (32) pears likely that enhancer element C defined by Veldman et al. (14) and the fi regulatory region defined by Maione et al. (32) are equivalent and that the function of this region is mediated by EF-C binding.
A 6-bp inverted repeat, separated by 3 bp, is contained symmetrically within the boundaries ofthe region of nuclease protection conferred by EF-C binding. The EF-C protein, therefore, may bind as a dimer. Two lines ofevidence support this possibility. First, a number of DNase I hypersensitive cleavage sites were observed that are located outside the footprint (for example, see Fig. 3 ). While the intensity of these sites varied from experiment to experiment, the same DNase I hypersensitive cleavage sites were consistently observed and map to nucleotides that are 6, 9, and 11 bp on the 5' side of the upstream repeat and 7, 10, and 12 bp on the 3' side of the downstream repeat. Thus, hypersensitive sites induced by EF-C binding symmetrically flank the inverted repeat sequence. Second, a single copy of the repeated sequence located on the early side of the polyoma replication origin did not detectably bind EF-C. Thus we speculate that EF-C binding is stabilized by dimerization.
Several other groups have defined nuclear factors that interact with the polyoma Pvu II fragment 4. The factor described by Fujimura (33) binds to a region that precisely corresponds to the EF-C binding domain and these two factors are undoubtedly the same. Nuclear factors identified by Piette et al. (34) and Bohnlein and Gruss (35) also bind to the Pvu II fragment 4. The predominant binding activity observed by these authors corresponds to element B of the enhancer region (Fig. 1 ). This region is immediately adjacent to the EF-C binding domain. It will be interesting to determine whether the factors that bind these two elements interact with each other.
